VARDITRA 40

What is VARDITRA 40?

VARDITRA 40 is a highly effective medication designed to restore and normalize erectile function in adult men. The medicinal product is produced in the form of film-coated tablets, which ensures dosage accuracy and convenience of oral administration. The pharmacological group of the drug is selective phosphodiesterase type 5 inhibitors, which purposefully affect the vascular system of the genital organ, improving the blood filling of the cavernous bodies. The manufacturer of this high-quality generic is the Indian pharmaceutical company Healing Pharma, which has established itself as a reliable developer of safe and effective drugs in accordance with international GMP standards.

The main active substance of VARDITRA 40 is vardenafil at a dosage of 40 milligrams, belonging to the class of potent locally acting vasodilators. The drug is not a hormonal agent and does not affect libido, but only provides a physiological response to sexual stimulation. Due to its high bioavailability and fast onset of action, VARDITRA 40 allows achieving a stable erection sufficient for full sexual intercourse. The drug has undergone numerous clinical studies confirming its effectiveness even in patients with concomitant conditions such as diabetes mellitus or arterial hypertension. It is worth noting that VARDITRA 40 is a generic of the original drug Levitra, but at a significantly more affordable price.

The mechanism of action of VARDITRA 40 is based on blocking the phosphodiesterase type 5 enzyme, which is responsible for the breakdown of cyclic guanosine monophosphate in the cavernous bodies of the penis. This leads to the relaxation of the smooth muscles of the arteries and an increase in blood flow, which ensures the occurrence and maintenance of an erection. The drug acts exclusively in the presence of natural sexual arousal, so it does not cause spontaneous erections at rest. This approach makes VARDITRA 40 a safe and physiological agent for correcting erectile dysfunction of various origins.

What is VARDITRA 40 prescribed for?

The main indication for the use of VARDITRA 40 is erectile dysfunction — a condition in which a man cannot achieve or maintain an erection sufficient for satisfactory sexual intercourse. This problem can have a psychogenic, organic, or mixed origin, and the drug demonstrates high efficacy in all cases. VARDITRA 40 helps restore self-confidence and improve the quality of intimate life. The drug is especially recommended for patients who have not received the desired result from lower doses of vardenafil or other PDE-5 inhibitors.

The second important area of application of VARDITRA 40 is support of erectile function in chronic diseases that negatively affect the vascular system. Diabetes mellitus, atherosclerosis, hypertension, and metabolic syndrome are often accompanied by impaired blood circulation in the pelvic organs. VARDITRA 40 compensates for these disorders by improving microcirculation and restoring a normal vascular response to sexual stimuli. Clinical experience shows that even patients with a long history of diabetes can achieve a significant improvement in erectile function.

VARDITRA 40 is also used in the complex therapy of psychogenic erectile dysfunction caused by stress, anxiety, or depressive states. In such cases, the drug acts as a kind of "bridge" that allows breaking the vicious circle of failures and restoring the patient's confidence. After several successful sexual acts, the psychological barrier usually disappears, and the need for constant use of the drug can significantly decrease. It is important to understand that VARDITRA 40 is not an aphrodisiac and does not increase sexual desire, but only provides the technical capability to realize natural desire.

Composition and active components of VARDITRA 40

The active pharmaceutical ingredient of VARDITRA 40 is vardenafil hydrochloride in the amount of 40 milligrams per tablet. Vardenafil is a selective phosphodiesterase type 5 inhibitor that differs in chemical structure from sildenafil and tadalafil, which provides it with a unique action profile. The substance is rapidly absorbed in the gastrointestinal tract, reaching maximum plasma concentration approximately 30–60 minutes after ingestion. The elimination half-life of vardenafil is about 4–5 hours, which provides a sufficient duration of the therapeutic effect without excessive accumulation in the body.

Excipients of VARDITRA 40 include microcrystalline cellulose, crospovidone, magnesium stearate, and hypromellose, which perform the functions of fillers, binding agents, and tablet shape stabilizers. The film coating consists of hypromellose, titanium dioxide, macrogol, and colorants that protect the active component from external factors. All excipients are pharmaceutically inert and do not affect the therapeutic effect of the drug. They have undergone thorough safety controls in accordance with the requirements of international pharmacopoeias.

The mechanism of action of vardenafil consists in the selective inhibition of the phosphodiesterase type 5 enzyme, which prevents the degradation of cyclic guanosine monophosphate. This molecule is a key mediator of the relaxation of the smooth muscles of the penile vessels, so its accumulation leads to pronounced vasodilation and increased blood filling of the cavernous bodies. Vardenafil demonstrates high selectivity for PDE-5 compared to other enzyme isoforms, which minimizes the risk of systemic side effects. The drug does not affect the heart muscle directly, but may cause a slight decrease in blood pressure due to its vasodilatory action.

Dosage of VARDITRA 40

The standard recommended dose of VARDITRA 40 for adult men is one 40 mg tablet 25–60 minutes before planned sexual activity. This dosage is increased compared to the initial therapeutic dose of vardenafil of 10–20 mg, so its use is appropriate only in cases of insufficient efficacy of lower doses. The maximum daily dose should not exceed 40 mg, which is one tablet per day. Exceeding the recommended dosage does not lead to an increase in the therapeutic effect, but significantly increases the risk of side effects.

For elderly patients over 65 years of age, dose adjustment is usually not required, but it is recommended to start therapy with minimal doses to evaluate individual tolerance. Men with mild to moderate hepatic impairment should limit the dose to 20 mg per day, and in severe hepatic impairment, the drug is contraindicated. Patients with severe renal impairment are also recommended to reduce the dose to 20 mg. The duration of the treatment course is determined individually depending on the cause of erectile dysfunction and the response to therapy.

VARDITRA 40 is intended for as-needed use, rather than continuous daily use, although in certain clinical situations a doctor may recommend regular low doses. The frequency of administration should not exceed once a day, regardless of the number of sexual contacts. If there is no effect from the drug after several attempts, it is necessary to consult a doctor to review the diagnosis and treatment tactics. Increasing the dose or frequency of intake on your own is strictly prohibited.

How to take VARDITRA 40 correctly?

The VARDITRA 40 tablet should be taken orally, washed down with a sufficient amount of water, regardless of food intake. However, it should be kept in mind that fatty food can slow down the absorption of the drug and delay the onset of the effect by 30–60 minutes. To achieve the fastest result, it is recommended to take the tablet on an empty stomach or after a light snack. The tablet should not be chewed or crushed, as this may violate the integrity of the film coating and alter the pharmacokinetics of the active substance.

The optimal time to take VARDITRA 40 is 30–60 minutes before expected sexual contact, although the therapeutic effect can last up to 8–10 hours. The drug works only in the presence of sexual stimulation, so it is important to provide an appropriate atmosphere and mood. If a dose was missed, do not double the next dose — it is enough to take a tablet when the need arises. In case of an accidental overdose, seek immediate medical attention, as a significant drop in blood pressure and cardiac arrhythmias may occur.

During VARDITRA 40 therapy, grapefruit juice should be avoided, as it can increase the concentration of the drug in the blood and enhance the risk of side effects. Moderate alcohol consumption usually does not affect the efficacy of the drug, but excessive intake can cause dizziness and a drop in blood pressure. It is important to remember that VARDITRA 40 does not protect against sexually transmitted infections, so appropriate safety measures should be observed.

Side effects of VARDITRA 40

The most common side effects of VARDITRA 40 are headache, hot flashes, nasal congestion, and dyspeptic symptoms. These reactions occur as a result of the vasodilatory action of the drug and are usually mild to moderate in nature. Headache is observed in approximately 10–15% of patients and usually resolves on its own within a few hours. Hot flashes and facial flushing are associated with the expansion of peripheral vessels and do not require special treatment.

Less common adverse reactions include dizziness, visual disturbances, back and muscle pain, increased sensitivity to light. Visual disturbances may manifest as a change in color perception or increased brightness of light, which is caused by the effect on phosphodiesterase type 6 in the retina of the eye. These phenomena are temporary and completely disappear after the elimination of the drug from the body. In rare cases, the development of priapism is possible — a prolonged painful erection lasting more than 4 hours, which requires immediate medical attention.

Rare but serious side effects of VARDITRA 40 are sudden loss of hearing or vision, cardiovascular complications, allergic reactions. Patients with heart conditions should be especially careful, as the drug can cause a significant decrease in blood pressure. In case of chest pain, shortness of breath, severe dizziness, or allergic manifestations, immediately discontinue the drug and consult a doctor. The individual response of the body may vary, so it is important to closely monitor your well-being after the first dose.

Contraindications of VARDITRA 40

Absolute contraindications to the use of VARDITRA 40 are the simultaneous administration of nitrates or nitric oxide donors in any dosage form. Combining vardenafil with nitroglycerin, isosorbide dinitrate, or other nitrates can lead to a catastrophic drop in blood pressure, which is life-threatening for the patient. The drug is also prohibited in case of hypersensitivity to vardenafil or any excipient. For patients with severe hepatic impairment, end-stage renal failure, and hypotension, VARDITRA 40 is not prescribed.

Relative contraindications requiring special caution are cardiovascular diseases in which sexual activity is undesirable. These include unstable angina, severe heart failure, recent myocardial infarction, or stroke. For patients with anatomical deformation of the penis, such as Peyronie's disease, or conditions predisposing to priapism, the drug is prescribed with caution. In hereditary degenerative diseases of the retina, such as retinitis pigmentosa, the use of PDE-5 inhibitors is not recommended.

VARDITRA 40 is not intended for use in women, children, and adolescents under 18 years of age. The drug has no indications for the treatment of female sexual dysfunction, and its safety for this category of patients has not been established. Men planning fatherhood should consult a doctor regarding the possible impact of the drug on fertility. Before starting VARDITRA 40 therapy, a consultation with a physician is mandatory to rule out hidden cardiovascular diseases and to assess the benefit-to-risk ratio.

Interaction of VARDITRA 40 with other drugs and alcohol

The most dangerous drug interaction of VARDITRA 40 is the combination with nitrates and nitric oxide donors, which can cause an uncontrolled decrease in blood pressure. Co-administration with alpha-blockers used to treat prostatic hyperplasia should also be avoided, as an enhancement of the hypotensive effect is possible. CYP3A4 inhibitors, such as ketoconazole, itraconazole, ritonavir, and clarithromycin, can significantly increase the concentration of vardenafil in the blood, so when used together, the dose of the drug should be reduced. Other PDE-5 inhibitors should not be used simultaneously with VARDITRA 40 due to the risk of a cumulative effect.

Moderate amounts of alcohol usually do not affect the pharmacokinetics of VARDITRA 40, however excessive alcohol consumption can exacerbate side effects, such as dizziness, headache, and orthostatic hypotension. In addition, alcohol itself is a central nervous system depressant and can impair erectile function, negating the therapeutic effect of the drug. During therapy, it is recommended to limit alcohol consumption to minimal doses. Regarding driving vehicles, VARDITRA 40 can cause dizziness and visual disturbances, so until individual reactions are determined, one should refrain from driving and operating machinery.

Where to buy VARDITRA 40 in Ukraine

VARDITRA 40 is available for purchase in pharmacy chains of Ukraine by prescription, as well as through specialized online platforms that deliver medicines. Before purchasing, it is important to check the vendor's license and the drug's compliance with the original packaging of the manufacturer Healing Pharma. The price of VARDITRA 40 may vary depending on the region, pharmacy chain, and the number of tablets in the package. Ordering online often allows you to get a better price and convenient delivery to the nearest post office or by courier.

VARDITRA 40 must be stored in a dry, light-protected place at a temperature not exceeding 25 degrees Celsius, out of reach of children. The shelf life of the drug is usually 24 months from the date of manufacture, after which its use is strictly prohibited. Before starting the intake, be sure to consult a doctor to determine the optimal dosage and exclude contraindications. Remember that self-medication can be dangerous to your health, and the body's individual response to the drug may differ from expected.